Novozymes A/S Updates on Appointment of New President and Chief Executive Officer

Novozymes A/S announced that the Board of Directors has appointed Mr. Peder Holk Nielsen President and Chief Executive Officer (CEO) with effect from April 1, 2013. Mr. Nielsen will replace the current President and CEO, Mr. Steen Riisgaard, who after 12 years as CEO, and 33 years at Novozymes A/S and Novo Industri/Novo Nordisk steps down according to plan. Mr. Nielsen is currently Executive Vice President and Head of Enzyme Business, a position he has held since 2007. Mr. Nielsen’s career spans management positions within Novozymes A/S and Novo Industri/Novo Nordisk across business development, Research and Development, quality management, and sales and marketing.